ArticleBMC veterinary research2025
Relationship between dog erythrocyte antigen (DEA) and susceptibility of dogs to babesiosis.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine Babesiosis causes a fatal disease marked by haemolytic anaemia. Of the identified dog blood groups, some have been found to affect the host's susceptibility/resistance to certain infections. However, limited information exists on the influence of canine blood types on tolerance of dogs to babesiosis. This study assessed the prevalence of different Dog Erythrocyte Antigen (DEA) 1 blood group in Abeokuta, Nigeria, and evaluated potential relationship between DEA 1 blood types and susceptibility to babesiosis. 200 blood samples (1 mL each) were collected from client-owned dogs. Alvedia® test kit was used to identify DEA 1.1, DEA 1.2 and DEA 1.0 genotypes. Deoxyribose nucleic acid (DNA) was extracted from each sample, and Babesia species detected using Polymerase Chain Reaction (PCR). Data were analyzed for relationship between blood types and Babesia infection using Chi-square. DEA 1 positive dogs accounted for 63.5%, a significantly higher proportion than DEA 1 negative dogs (36.5%) in the study population. Boerboel, Rottweiler, Caucasian, and local breeds showed significantly higher frequency (73.3% to 86.4%) of DEA 1 positive blood types compared to DEA 1 negative types (13.6% to 26.7%). In contrast, German shepherd breed showed no significant difference in frequency of DEA positive (51.2%) and DEA negative (48.8%) dogs. Additionally, no significant sex-based differences were observed in DEA 1 blood type distribution. The prevalence of Babesia species in DEA 1 positive dogs (63.0%) was not significantly different (p > 0.05) from that in DEA 1 negative dogs (60.3%). These findings suggested that the DEA 1 blood group may not influence the tolerance or susceptibility of dogs to Babesia infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.